Please enable Javascript to use all features and improve your user experience.
Epilepsie 2023
Programme
Posters
People
Search
DE
Back
Vortrag
Neue Therapieoption für das Lennox-Gastaut-Syndrom – die Zulassung von Fenfluramin
Redner
Susanne Schubert-Bast
Frankfurt a. M. / DE
Appointment
Date:
16/03/2023
Time:
11:15
–
11:45
Talk time:
25 Min.
Discussion time:
5 Min.
Location / Stream:
Hörsaal A
Session
Innovationen in der Behandlung therapieschwieriger Epilepsien
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy